CONTEXT THERAPEUTICS INC (CNTX) Stock News
USA - NASDAQ:CNTX - US21077P1084 - Common Stock
1.28 USD
+0.07 (+5.79%)
1.3 USD
+0.02 (+1.56%)
CNTX Latest News, Press Relases and Analysis
All
Press Releases
18 days ago - By: Context Therapeutics Inc.
18 days ago - By: Context Therapeutics Inc.
20 days ago - By: Context Therapeutics Inc.
20 days ago - By: Context Therapeutics Inc.
6 months ago - By: Context Therapeutics Inc.
2 months ago - By: Context Therapeutics Inc.
2 months ago - By: Context Therapeutics Inc.
3 months ago - By: Context Therapeutics Inc.
3 months ago - By: Context Therapeutics Inc.
5 months ago - By: Context Therapeutics Inc.
5 months ago - By: Context Therapeutics Inc.
5 months ago - By: Context Therapeutics Inc.
5 months ago - By: Context Therapeutics Inc.
5 months ago - By: Context Therapeutics Inc.
5 months ago - By: Context Therapeutics Inc.
6 months ago - By: Context Therapeutics Inc.
6 months ago - By: Context Therapeutics Inc.
6 months ago - By: Context Therapeutics Inc.
6 months ago - By: Context Therapeutics Inc.
6 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
7 months ago - By: Context Therapeutics Inc.
8 months ago - By: Context Therapeutics Inc.
8 months ago - By: Context Therapeutics Inc.
8 months ago - By: Context Therapeutics Inc.
8 months ago - By: Context Therapeutics Inc.